Our People

Employed by Lendlease Corporation as the Group Risk and Insurance Manager, Alistair is responsible for the implementation of the global risk and insurance strategy across the Group’s regional businesses. This role provides strategic direction, technical advice and support on risk mitigation, insurance programme development and management and business continuity & crisis management expertise to the Group’s operations. Alistair holds a Bachelor of Arts from University of Sydney, a Master of Insurance & Risk Management and a Master of Business Administration from Deakin University. Based in Sydney, Alistair has worked extensively through Europe, North America and the Asia Pacific regions.

Lisa is a lecturer at the University of Technology Sydney, where she teaches in the genetic counselling program and conducts research on ethics of genetics and genomics. She has also been a research fellow at Sydney Health Ethics at the University of Sydney, and has taught ethics and philosophy in the various undergraduate and postgraduate programs. Previously, she managed a team of policy and advocacy staff at The Royal Australasian College of Physicians and has also worked as an organisation development consultant, helping non-profit sector clients respond to organisational and governance challenges. Lisa graduated from the AICD Company Directors Course in 2022.

He has also had the opportunity to successfully lead Crisis Management programs, helping businesses recover from problems, whether it be in Supply Chain, Sales or IT. Throughout his career Jeff has been recognised as a leading communicator and facilitator, he enjoys the opportunity to lead workshops, helping teams develop strategies and initiatives that help their businesses grow. As a graduate of the Australian Institute of Company Directors, Jeff brings a desire to help EAA grow and thrive through application of Risk Management and Governance.

Jeff’s son Jake (Born 2000) has a significant intellectual disability and was diagnosed with Epilepsy – Absence Seizures in 2022, so he and wife Jane and daughter Emma, have recent experience dealing with a diagnosis. Jeff’s family are very connected to the National Disability Insurance Support scheme and other support mechanisms and are passionate about helping people navigate their journey through it.

Carol currently serves on the federal government’s Australian Advisory Council on the Medicinal Use of Cannabis, the Advisory Board of the Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney, and the Steering Committee for the NSW Government’s Paediatric Epilepsy Trials (Medicinal Cannabis Research). She is a founding director of the Medical Cannabis Council, a peak industry body. Carol is a strong and active advocate for people living with epilepsy.

Martin has worked his entire professional life in the securities industry, starting in 1979 on the Sydney ASX trading floor as a telephone clerk and seconded to broking firms in London during the 1980s. He joined Macquarie in 1994, where he has since held roles in Macquarie Equities Institutional sales, headed the Asia desk and more recently in Macquarie Wealth Management where he became a Division Director in 2006. Martin is also a senior investment adviser within the Macquarie Private Bank. Martin has a family member living with epilepsy.

Prior to his retirement in early 2016, Roy had international assignments as Director – Finance and Administration International Operations at URS. He first became acquainted with Epilepsy Action Australia in 2011 when tragically, his oldest son George, aged 29 passed away suddenly as result of epilepsy. Since this time Roy and his family have become strong supporters of Epilepsy Action.

DrJMT has worked in all sectors both internationally and within Australia. She was the former CEO of a national charity, leading one of Australia’s prominent mergers between a national and international charity.  Her Board commitments include being a community member on the NSW Nursing and Midwifery Council. Recently she held the champion role of Volunteer Family Connect a structured social relationships approach that reduces isolation for children and families through the connection with volunteers and home visiting.

David’s daughter Luella was diagnosed with a severe paediatric epilepsy at just 11 weeks of age.  Now 4, Luella continues to struggle for seizure control and has complex special needs as a result of her ongoing seizures.  In recent years, David and his wife Erin have turned their mind to raising awareness and funds to support paediatric epilepsy.

Erin and her family continue to struggle to achieve seizure control for Lulu, and as a result her diagnosis has developed into Lennox Gastaut Syndrome, an equally severe form of epilepsy. Luella, now 4 years old, has complex special needs and requires Erin’s full time care.

Since Luella’s diagnosis, Erin has become a leading advocate for families dealing with childhood epilepsy founding the Lulu Love Project (LLP) and over the past three years has raised close to $500,000 for LLP and Epilepsy Action Australia. Erin’s goal is to continue shining a brighter light on epilepsy through social media and helping to raising essential funds for epilepsy.

Alan’s career in research and consultancy took him from London to Singapore and on to Sydney where he co-founded RFI Global in 2006. Over the last 17 years RFI has grown from a start-up of 2 people to a global brand relied on by the world’s largest banking and technology companies.

Alan’s connection to epilepsy is through his daughter Mila, who has a rare genetic condition that causes seizures. Since learning of her diagnosis Alan has been keen to get involved and support Epilepsy Action in any way he can.

When her son Max developed epilepsy at age three, she established the George Gregan Foundation to raise much needed funds to support research into childhood epilepsy and to design and build outdoor interactive playgrounds at children’s hospitals throughout Australia.  In addition to her business acumen, Erica’s skill set includes fundraising, event planning and developing key partnerships.

She currently sits on the Australian Advisory Council on the Medicinal Use of Cannabis, the Advisory Board of the Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney, and the Steering Committee for the NSW Government’s Paediatric Epilepsy Trials (Medicinal Cannabis Research). She is fully responsible for all operations of the company within the established policies, and in accordance with the authority delegated by the Board of Directors implements the strategic goals and objectives, giving direction and leadership toward the achievement of the organisation’s mission and strategy.

Lisa came to Epilepsy Action Australia with extensive experience in neuroscience and intensive care nursing, along with nurse education, which was utilised in the development of Epilepsy Action Australia’s Online Academy courses and resources. In her development work Lisa has utilised the experience gained during two periods of secondment: to the East Timor Epilepsy Project and the George Institute for Global Health.